Rekombinanter IGF1R (Figitumumab Biosimilar) Antikörper
Kurzübersicht für Rekombinanter IGF1R (Figitumumab Biosimilar) Antikörper (ABIN7487920)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Expressionssystem
- Mammalian cells
-
Verwendungszweck
- Figitumumab Biosimilar - Anti-IGF1R, CD221 mAb
-
Produktmerkmale
- Antibody Type: IgG2-kappa
-
Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotyp
- IgG2
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS pH 7.5
-
Lagerung
- -80 °C
-
Informationen zur Lagerung
- store at -80°C
-
-
- IGF1R (Figitumumab Biosimilar)
-
Substanzklasse
- Biosimilar
-
Hintergrund
-
CP-751871
Figitumumab (CP-751, 871, CP), a human anti-IGF-IR monoclonal antibody (mAb), is proved to have antiproliferation and anti-tumorigenicity effects in cancer cells and xenografted mice, and it has been showed to be effective in combination with other cytotoxic agents to target many cancer types. -
CAS-Nummer
- 943453-46-1
Target
-